It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cells infected with pathogens can contribute to clearing infections by releasing signals that instruct neighbouring cells to mount a pro-inflammatory cytokine response, or by other mechanisms that reduce bystander cells’ susceptibility to infection. Here, we show the opposite effect: epithelial cells infected with Salmonella Typhimurium secrete host factors that facilitate the infection of bystander cells. We find that the endoplasmic reticulum stress response is activated in both infected and bystander cells, and this leads to activation of JNK pathway, downregulation of transcription factor E2F1, and consequent reprogramming of microRNA expression in a time-dependent manner. These changes are not elicited by infection with other bacterial pathogens, such as Shigella flexneri or Listeria monocytogenes. Remarkably, the protein HMGB1 present in the secretome of Salmonella-infected cells is responsible for the activation of the IRE1 branch of the endoplasmic reticulum stress response in non-infected, neighbouring cells. Furthermore, E2F1 downregulation and the associated microRNA alterations promote Salmonella replication within infected cells and prime bystander cells for more efficient infection.
Cells infected with pathogens can release signals that instruct neighbouring cells to mount an immune response or that reduce these cells’ susceptibility to infection. Here, Aguilar et al. show the opposite effect: cells infected with Salmonella Typhimurium secrete host factors that facilitate the infection of bystander cells by activating their ER-stress response.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 University of Würzburg, Host RNA Metabolism Group, Institute for Molecular Infection Biology (IMIB), Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658)
2 University of Coimbra, RNA & Infection Laboratory, Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342); University of Coimbra, Functional Genomics and RNA-based Therapeutics Laboratory, Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342); University of Coimbra, PhD Programme in Experimental Biology and Biomedicine (PDBEB), Institute for Interdisciplinary Research (IIIUC), Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342)
3 University of Würzburg, Host RNA Metabolism Group, Institute for Molecular Infection Biology (IMIB), Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); Institut Pasteur, Biology of Infection Unit, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535)
4 Homi Bhabha National Institute (HBNI), The Institute of Mathematical Sciences (IMSc), Chennai, India (GRID:grid.450257.1) (ISNI:0000 0004 1775 9822)
5 University of Córdoba, Animal Breeding and Genomics Group, Department of Genetics, Faculty of Veterinary Science, Córdoba, Spain (GRID:grid.411901.c) (ISNI:0000 0001 2183 9102); Maimónides Biomedical Research Institute of Córdoba (IMIBIC), Immunogenomics and Molecular Pathogenesis GA14 Group, Córdoba, Spain (GRID:grid.428865.5) (ISNI:0000 0004 0445 6160)
6 University of Coimbra, Functional Genomics and RNA-based Therapeutics Laboratory, Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342); University of Coimbra, Department of Life Sciences, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342)
7 University of Würzburg, Host RNA Metabolism Group, Institute for Molecular Infection Biology (IMIB), Würzburg, Germany (GRID:grid.8379.5) (ISNI:0000 0001 1958 8658); University of Coimbra, RNA & Infection Laboratory, Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342); University of Coimbra, Department of Life Sciences, Coimbra, Portugal (GRID:grid.8051.c) (ISNI:0000 0000 9511 4342)